Important update: UPMC Health Plan 835 readmits

May 2024Important Notices

UPMC Health Plan has discovered an issue with some of the Electronic Remittance Advice (835) data that was sent to providers. The issue—which is related to a systems enhancement—exists only within the 835 data. No issues have been found on Explanations of Payment or Explanations of Benefits.

The enhancement was implemented on April 25, 2024. As such, 835s created on or after April 26 may have been impacted.

Please note that we are working on a change that should resolve the issue within the next week, and we hope to provide a count of the providers and claims that were impacted. In the meantime, we have rolled back the 835 enhancements so that all 835s created on or after May 7 at 3 p.m. are correct.

If you have any questions about this matter, please contact your physician account executive or call Provider Services at 1-866-918-1595.


Recent Announcements

Important announcement – Telehealth submissions

As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.
Sep. 2025Important Notices

October 2025 UPMC for You and UPMC Community HealthChoices Formulary Update

Effective October 1st, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to non-participation in the Medicaid Drug Rebate Program.
Sep. 2025Pharmacy Updates

Biosimilar Medication Formulary Updates

Updates to formulary biosimilar medications for denosumab, eculizumab, and ustekinumab products
Sep. 2025Pharmacy Updates